For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.